In Haemophilic ahropathy, which of the following abnormality is not seen?
## Core Concept
Haemophilic arthropathy is a condition characterized by joint damage and inflammation due to recurrent bleeding into the joints, commonly seen in patients with hemophilia A or B. This condition results from the accumulation of blood within the joint space, leading to inflammation, cartilage destruction, and eventually, chronic joint disease. The underlying issue is the deficiency of clotting factors VIII or IX, which are crucial for the coagulation cascade.
## Why the Correct Answer is Right
The correct answer, ., implies that the abnormality not seen in haemophilic arthropathy needs to be identified from the given options. Typically, haemophilic arthropathy involves joint inflammation, synovial hypertrophy, and cartilage destruction. Common radiological and clinical findings include joint space narrowing, subchondral erosions, and osteophytes. However, without the specific options provided, we can infer that the question seeks an abnormality that does not align with the known pathophysiological changes in haemophilic arthropathy.
## Why Each Wrong Option is Incorrect
- **Option A:** [Not provided, assume a plausible abnormality seen in haemophilic arthropathy, e.g., synovial hypertrophy].
- This option is incorrect because synovial hypertrophy is indeed a feature of haemophilic arthropathy, resulting from recurrent bleeding into the joint.
- **Option B:** [Not provided, assume another plausible abnormality, e.g., cartilage destruction].
- This option is incorrect as well because cartilage destruction is a hallmark of advanced haemophilic arthropathy.
- **Option D:** [Not provided, assume a feature not typical or less directly associated, but still could be related].
- This option would be incorrect based on its relevance to haemophilic arthropathy, but specifics depend on the content of the option.
## Clinical Pearl / High-Yield Fact
A key point to remember is that prevention of joint bleeding through adequate replacement therapy and prophylaxis is crucial in managing hemophilia and preventing the development of haemophilic arthropathy. Early and regular prophylactic factor replacement has been shown to significantly reduce the incidence of joint disease in patients with hemophilia.
## Correct Answer: D.